Akalin E - Search Results

1

Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates.

Girnita AL, Wang L, Colovai AI, Ahearn P, Azzi Y, Menon MC, Fernandez-Vina M, Gebel HM, Steve Woodle E, Cravedi P, Maltzman JS, Akalin E. Girnita AL, et al. Among authors: akalin e. Transplantation. 2022 Oct 1;106(10):2085-2091. doi: 10.1097/TP.0000000000004277. Epub 2022 Sep 2. Transplantation. 2022. PMID: 36070571 Free PMC article.

2

Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology.

Akalin E, Hendrix RC, Polavarapu RG, Pearson TC, Neylan JF, Larsen CP, Lakkis FG. Akalin E, et al. Transplantation. 2001 Sep 15;72(5):948-53. doi: 10.1097/00007890-200109150-00034. Transplantation. 2001. PMID: 11571464

3

The influence of Duffy blood group on renal allograft outcome in African Americans.

Akalin E, Neylan JF. Akalin E, et al. Transplantation. 2003 May 15;75(9):1496-500. doi: 10.1097/01.TP.0000061228.38243.26. Transplantation. 2003. PMID: 12792503

4

Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.

Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS. Akalin E, et al. Transplantation. 2003 Nov 27;76(10):1444-7. doi: 10.1097/01.TP.0000084200.40159.EC. Transplantation. 2003. PMID: 14657683

5

Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease.

Paramesh AS, Roayaie S, Doan Y, Schwartz ME, Emre S, Fishbein T, Florman S, Gondolesi GE, Krieger N, Ames S, Bromberg JS, Akalin E. Paramesh AS, et al. Among authors: akalin e. Clin Transplant. 2004 Feb;18(1):94-9. doi: 10.1046/j.1399-0012.2003.00132.x. Clin Transplant. 2004. PMID: 15108777

6

Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.

Akalin E, Ames S, Sehgal V, Murphy B, Bromberg JS. Akalin E, et al. Clin Transplant. 2005 Jun;19(3):364-6. doi: 10.1111/j.1399-0012.2005.00350.x. Clin Transplant. 2005. PMID: 15877799

7

A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients.

Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu YM, Katz SM, Akalin E, Esterl R, Gugliuzza K, Shihab F, Jordan S, Jonsson J, Molmenti E, Barbeito R. Vincenti F, et al. Among authors: akalin e. Transplantation. 2005 Oct 15;80(7):910-6. doi: 10.1097/01.tp.0000173802.70980.50. Transplantation. 2005. PMID: 16249738 Clinical Trial.

8

Differential expression of profibrotic and growth factors in chronic allograft nephropathy.

Hotchkiss H, Chu TT, Hancock WW, Schröppel B, Kretzler M, Schmid H, Liu Y, Dikman S, Akalin E. Hotchkiss H, et al. Among authors: akalin e. Transplantation. 2006 Feb 15;81(3):342-9. doi: 10.1097/01.tp.0000195773.24217.95. Transplantation. 2006. PMID: 16477218

9

The burden of chronic kidney disease in long-term liver transplant recipients.

de Boccardo G, Kim JY, Schiano TD, Maurette R, Gagliardi R, Murphy B, Emre S, Akalin E. de Boccardo G, et al. Among authors: akalin e. Transplant Proc. 2008 Jun;40(5):1498-503. doi: 10.1016/j.transproceed.2008.03.099. Transplant Proc. 2008. PMID: 18589138

10

Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.

Akalin E, Ganeshan SV, Winston J, Muntner P. Akalin E, et al. Transplantation. 2008 Sep 15;86(5):652-8. doi: 10.1097/TP.0b013e3181814f5b. Transplantation. 2008. PMID: 18791445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters